Growth & Finance

July 18, 2023

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck

Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.

Ann Walker, Research Assistant III, spins blood samples on a carousel prior to DNA extraction.
July 18, 2023

Alliance for Genomic Discovery FAQs

Here are frequently asked questions about Vanderbilt University Medical Center’s Alliance for Genomic Discovery.

June 27, 2023

Embí to help steer national AI code of conduct initiative

Vanderbilt’s Peter Embí, MD, MS, has been named to a National Academy of Medicine committee working to produce a code of conduct for the development and use of artificial intelligence in health, medical care and health research.

March 28, 2023

Behavioral Health Clinical Services Center formed

The newly developed Behavioral Health Clinical Services Center provides a professional home for licensed and license-eligible, non-physician behavioral health providers who are delivering assessment, diagnosis and intervention to patients receiving services throughout Vanderbilt University Medical Center.

This rendering shows the layout of one of the 10 operating rooms at Monroe Carell Jr. Children’s Hospital at Vanderbilt that will be renovated.
February 9, 2023

Operating rooms at Monroe Carell Jr. Children’s Hospital at Vanderbilt set for major renovation

Monroe Carell Jr. Children’s Hospital at Vanderbilt is set to begin the first major renovation of its operating rooms since the hospital opened 19 years ago.

array of test tubes with pipette dropping fluid into one
February 2, 2023

VU, VUMC rise in National Science Foundation survey

Vanderbilt University and Vanderbilt University Medical Center climbed seven spots in a survey by the National Science Foundation that measures annual research and development expenditures.